| Home | E-Submission | Sitemap | Editorial Office |  
top_img
      
REVIEW ARTICLE 2019 May 3
Autoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis
Purpose Autoimmunity is an alternative etiology of gastric inflammation, the initiating event in the gastric carcinogenic cascade. This mechanism may be an increasingly important cause of gastric cancer with the waning prevalence of its primary etiologic factor, chronic Helicob...
SPECIAL ARTICLE 2019 June 7
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
Purpose A cross-sectional survey was conducted to explore the current awareness and use of complementary and alternative medicine (CAM), as well as attitudes toward CAM, in patients with cancer and their family members in South Korea. Materials and Methods Between September 2...
ORIGINAL ARTICLE 2018 October 1
A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1-Overexpressing Tumors in vivo
Purpose This study was carried out to identify a peptide that selectively binds to kidney injury molecule-1 (KIM-1) by screening a phage-displayed peptide library and to use the peptide for the detection of KIM-1overexpressing tumors in vivo. Materials and Methods Biopanning ...
ORIGINAL ARTICLE 2018 October 2
Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer
Purpose The purpose of this study was to determine whether histologic inflammation (HI) in initial and repeat prostate biopsy specimens was significantly associated with the detection of prostate cancer. Materials and Methods Between 2005 and 2017, the clinicopathological rec...
ORIGINAL ARTICLE 2018 October 2
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Purpose Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell lymphoma (DLBCL). It is unknown whether the dose-dense R-CHOP (R-CHOP-14) could improve the outcome of the dise...
ORIGINAL ARTICLE 2018 October 4
The Health Burden of Cancer Attributable to Obesity in Korea: A Population-Based Cohort Study
Purpose Considering the health impact of obesity and cancer, it is important to estimate the burden of cancer attributable to high body mass index (BMI). Therefore, the present study attempts to measure the health burden of cancer attributable to excess BMI, according to cancer...
Current Issue
Volume 51(3); Jul 2019
Volume 51(2); April 2019
Volume 51(1); January 2019
RSS feed

  • Most-cited are based on citations from 2017 ~ 2019.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2017;49(2):292-305.   Published online March 9, 2017    DOI: https://doi.org/10.4143/crt.2017.118
                                     Cited By 201
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2018;50(2):303-316.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.143
                                     Cited By 81
    Prediction of Cancer Incidence and Mortality in Korea, 2017
    Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee
    Cancer Res Treat. 2017;49(2):306-312.   Published online March 17, 2017    DOI: https://doi.org/10.4143/crt.2017.130
                                     Cited By 41
    Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Hae Il Jung, Dongjun Jeong, Sanghee Ji, Tae Sung Ahn, Sang Ho Bae, Susie Chin, Jun Chul Chung, Hyung Chul Kim, Moon Soo Lee, Moo-Jun Baek
    Cancer Res Treat. 2017;49(1):246-254.   Published online July 7, 2016    DOI: https://doi.org/10.4143/crt.2016.066
                                     Cited By 26
    The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
    Jaeyun Jung, Hyang Sook Seol, Suhwan Chang
    Cancer Res Treat. 2018;50(1):1-10.   Published online September 13, 2017    DOI: https://doi.org/10.4143/crt.2017.307
                                     Cited By 21
    Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012
    Mina Suh, Seolhee Song, Ha Na Cho, Boyoung Park, Jae Kwan Jun, Eunji Choi, Yeol Kim, Kui Son Choi
    Cancer Res Treat. 2017;49(3):798-806.   Published online November 11, 2016    DOI: https://doi.org/10.4143/crt.2016.186
                                  Supplementary         Cited By 17
    An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
    In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro
    Cancer Res Treat. 2017;49(3):569-577.   Published online September 12, 2016    DOI: https://doi.org/10.4143/crt.2016.289
                                     Cited By 16
    Lung Cancer Epidemiology in Korea
    Aesun Shin, Chang-Mo Oh, Byung-Woo Kim, Hyeongtaek Woo, Young-Joo Won, Jin-Soo Lee
    Cancer Res Treat. 2017;49(3):616-626.   Published online September 23, 2016    DOI: https://doi.org/10.4143/crt.2016.178
                                  Supplementary         Cited By 15
    Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
    Jörg U. Schmohl, Martin Felices, Felix Oh, Alexander J. Lenvik, Aaron M. Lebeau, Jayanth Panyam, Jeffrey S. Miller, Daniel A. Vallera
    Cancer Res Treat. 2017;49(4):1140-1152.   Published online February 20, 2017    DOI: https://doi.org/10.4143/crt.2016.491
                                     Cited By 15
    Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Kyung Su Kim, Jeanny Kwon, Kyubo Kim, Eui Kyu Chie
    Cancer Res Treat. 2017;49(3):824-833.   Published online August 26, 2016    DOI: https://doi.org/10.4143/crt.2016.336
                                     Cited By 14
    Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review
    Li-Tzong Chen, Do-Youn Oh, Min-Hee Ryu, Kun-Huei Yeh, Winnie Yeo, Roberto Carlesi, Rebecca Cheng, Jongseok Kim, Mauro Orlando, Yoon-Koo Kang
    Cancer Res Treat. 2017;49(4):851-868.   Published online January 3, 2017    DOI: https://doi.org/10.4143/crt.2016.176
                                  Supplementary         Cited By 14
    Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer
    In Hye Song, Sun-Hee Heo, Won Seon Bang, Hye Seon Park, In Ah Park, Young-Ae Kim, Suk Young Park, Jin Roh, Gyungyub Gong, Hee Jin Lee
    Cancer Res Treat. 2017;49(2):399-407.   Published online July 27, 2016    DOI: https://doi.org/10.4143/crt.2016.215
                                  Supplementary         Cited By 13
    Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN
    Tonglei Liu, Shuang Liu, Yu Xu, Ruo Shu, Feng Wang, Cheng Chen, Yujian Zeng, Huayou Luo
    Cancer Res Treat. 2018;50(4):1396-1417.   Published online January 24, 2018    DOI: https://doi.org/10.4143/crt.2017.537
                                     Cited By 13
    Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer
    Ga Won Yim, Hee Jung Kim, Lee Kyung Kim, Sang Wun Kim, Sunghoon Kim, Eun Ji Nam, Young Tae Kim
    Cancer Res Treat. 2017;49(3):656-668.   Published online October 11, 2016    DOI: https://doi.org/10.4143/crt.2016.263
                                     Cited By 12
    Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
    Jae-Hyeon Kim, Jun-Ho Ahn, Michael Lee
    Cancer Res Treat. 2017;49(4):947-959.   Published online January 3, 2017    DOI: https://doi.org/10.4143/crt.2016.280
                                  Supplementary         Cited By 12
    Prediction of Cancer Incidence and Mortality in Korea, 2018
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2018;50(2):317-323.   Published online March 21, 2018    DOI: https://doi.org/10.4143/crt.2018.142
                                     Cited By 12
    Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
    Mathias Lutz, Arik B. Schulze, Elisabeth Rebber, Stefanie Wiebe, Tarek Zoubi, Oliver M. Grauer, Torsten Keßler, Andrea Kerkhoff, Georg Lenz, Wolfgang E. Berdel
    Cancer Res Treat. 2017;49(2):548-552.   Published online July 12, 2016    DOI: https://doi.org/10.4143/crt.2016.110
                                     Cited By 11
    Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
    Kyung Jin Eoh, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Jeongwoo Han, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Eun Ji Nam
    Cancer Res Treat. 2017;49(2):408-415.   Published online July 27, 2016    DOI: https://doi.org/10.4143/crt.2016.135
                                     Cited By 11
    Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea
    Eun-Kyeong Moon, Chang-Mo Oh, Young-Joo Won, Jong-Keun Lee, Kyu-Won Jung, Hyunsoon Cho, Jae Kwan Jun, Myong Cheol Lim, Moran Ki
    Cancer Res Treat. 2017;49(2):526-533.   Published online September 1, 2016    DOI: https://doi.org/10.4143/crt.2016.316
                                     Cited By 11
    Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea
    Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Hyunsoon Cho, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
    Cancer Res Treat. 2017;49(3):607-615.   Published online September 23, 2016    DOI: https://doi.org/10.4143/crt.2016.139
                                  Supplementary         Cited By 11
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Cancer Research and Treatment 2017; 49(4): 915-926.
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community